Auransa

Developer of AI-based precision medicines for cancer

placePalo Alto, California, United States calendar_todayFounded 2014 groups12 employees language auransa.com

Innovation

11 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 558 times.

YearFilings
20181
20192
20205
20214
20225
20232
20242
20254
20261

Investor mix

6 investors on record; lead investors include Lux Capital.

Investor typeCountShare
Venture capital467%
Private equity117%
Other / undisclosed117%
Coming soon